Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

UCB’s Fintepla shows positives results for Lennox-Gastaut syndrome

The study demonstrated a sustained reduction in seizures for patients

- PMLiVE

Navigating the ‘Patient Metro’ – a journey full of insights

The key to unravelling its potential is to focus on the intersections where journeys are made or broken

- PMLiVE

The evolving world of pharma: trends challenges and opportunities

M3 EU recently surveyed 400 pharma marketers in the UK, Germany, France and Switzerland, and here’s what we heard: Budgets are shrinking, targets are climbing, and compliance requirements are getting...

M3 (EU)

- PMLiVE

FDA Fast Track designation given to Enterome’s follicular lymphoma treatment

Follicular lymphoma, a type of non-Hodgkin’s lymphoma, has few initial symptoms

- PMLiVE

Medicus Pharma recruits first patient in cancer patch trial

The first patient has been dosed as part of a phase 2 trial in the UAE

Genesis giveaway of a minifigure

Genesis Research Group contributes strong scientific program to ISPOR Europe and warmly invites visitors to booth 212

Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific program that includes an HEOR Theater session, contributions to 10...

Genesis Research Group

- PMLiVE

What to expect from Obesity Week 2025: Key trends shaping the future of obesity care

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.

Inizio

- PMLiVE

AI with intent: How Inizio is redefining pharma through precision and partnership

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...

Inizio

- PMLiVE

Aspire Pharma – enhancing the patient experience through stakeholder engagement

By Richard Condon

- PMLiVE

GSK’s Blenrep approved by FDA for multiple myeloma

Approval supported by positive results from phase 3 trial

- PMLiVE

Medherant announces positive phase 1 results for testosterone patch for women

University of Warwick spin-out develops first-in-class testosterone patch to support women through menopause

- PMLiVE

From insight to impact: strengthening stakeholder engagement across the patient journey

By Claire Paling

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links